Search Clinical Trials Parent Therapeutic Areas: Oncology | Obstetrics/Gynecology
Breast Cancer
State
Country
Alabama
Birmingham : Research Site:
A Study of R1507 in Combination With Letrozole in Postmenopausal Women With Advanced Breast Cancer
A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer
A Study to Assess Xeloda (Capecitabine) in Patients With Locally Advanced or Metastatic Breast Cancer
BETH Study: A Study of Avastin (Bevacizumab) in Combination With Chemotherapy + Herceptin (Trastuzumab) in Patients With HER2-Positive Early Breast Cancer.
Decatur : Research Site:
Huntsville : Research Site:
BEATRICE study: A Study of Avastin (Bevacizumab) Adjuvant Therapy in Triple Negative Breast Cancer.
Mobile : Research Site:
Mobile : Southern Cancer Center
First or Second Line Metastatic Breast Cancer with previous Avastin therapy
Various Cities : Research Center New!
The ?Bolero? HER2 Positive Breast Cancer Trial CRAD001J2301
Alaska
Anchorage : Providence Cancer Center (Katmai Oncology Group)
Anchorage : Alaska Cancer Research and Education Center
National Phase 2 Breast Cancer study investigating the effectiveness and safety of ZK-Epo in women with breast cancer that has spread to other parts of their bodies
Breast Cancer Study CZOL446E2352
Arizona
Chandler : Research Site:
A Study of Pertuzumab in Combination with Herceptin (Trastuzumab) and Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.
Flagstaff : Research Site:
Peoria : Merck
Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals
Phoenix : Research Site:
A Study to Evaluate the Efficacy and Safety of Herceptin (Trastuzumab) in Combination With an Aromatase Inhibitor in Patients With Metastatic Breast Cancer
Scottsdale : Research Site:
Sedona : Research Site:
Tucson : Research Site:
The ?Bolero? Metastatic Breast Cancer Trial CRAD001Y2301
Arkansas
Fayetteville : Research Site:
Fayetteville : Highlands Oncology Group
Hot Springs : Genesis Cancer Center
Jonesboro : Research Site:
Little Rock : Little Rock Hematology Oncology Associates
A study to compare 3 different treatment schedules of ABI-007 (Abraxane™) in combination with bevacizumab in women with metastatic breast cancer
Little Rock : Research Site:
California
Alhambra : Research Site:
Anaheim : Research Site:
Bakersfield : Research Site:
Bakersfield : Comprehensive Blood and Cancer Center
Baldwin Park : Research Site:
Bellflower : Research Site:
Beverly Hills : Research Site:
Burbank : Research Site:
Campbell : Research Site:
Chula Vista : Research Site:
Corona : Research Site:
Corona : ClinicAid Research Management/Compassionate Cancer Care Medical Group-Corona
Duarte : City of Hope
A Phase I/II Study of HKI-272 in Combination with Vinorelbine in Subjects with Solid Tumors and Metastatic Breast Cancer
A Translational Breast Cancer Prevention Trial of Mushroom Powder in Postmenopausal Breast Cancer Survivors
Age-Related Changes in Nanoparticle Albumin Bound (nab) Paclitaxel Pharmacokinetics and Pharmacodynamics
Blood Tumor Markers for Molecular Diagnosis of Breast Diseases and Monitoring of Breast Cancer Treatment and Follow-up
Characterization of Circulating Tumor Cells (CTCs) to Direct Pre-Operative and Systemic Therapy in Patients with Locally Advanced or Metastatic Stage IV Breast Cancer
Evaluation of Breast Cancer Patterns and Outcomes of Care
Intermittent Exemestane Therapy for Metastatic Breast Cancer
Long Term Follow-Up After Breast Cancer
Longitudinal Impact of Adjuvant Chemotherapy on Functional Status, Comorbidity and Quality of Life
Mindful Movement Program for Breast Cancer Survivors
NSABP B-42: A Clinical Trial to Determine the Efficacy of Five Years of Letrozole Compared to Placebo in Patients Completing Five Years of Hormonal Therapy Consisting of an Aromatase Inhibitor (A1) or Tamoxifen Followed by an AI in Prolonging Disease-Free Survival in Postmenopausal Women with Hormone Receptor Positive Breast Cancer
Patient Navigation in Breast Cancer Care; Addressing Barriers to Treatment Initiation, Completion, and Follow Up
Phase II Study of Tandem Cycle Dose-Intense Chemotherapy of Mephalan and Carboplatin, Thiotepa, and Cyclophosphamide (STAMP V)+/-Trastuzumab followed by Helical Tomotherapy or Local Regional Radiation Therapy for Stage IV Metastatic and Stage IIIB/C Breast Cancer
Randomized Phase II Study of Docetaxel, Adriamycin, and Cytoxan (TAC) Versus Adriamycin/Cytoxan, Followed By Abraxane/Carboplatin (ACAC) +/- Trastuzumab As Neoadjuvant Therapy for Patients with Stage I-III Breast Cancer
Reducing the Burden of Breast Cancer Among African American and Latina Survivors
The Effect of Aromatase Inhibition on the Cognitive Function of Older Patients with Breast Cancer
The Impact of Functional Strain on Psychological and Familial Functioning and Access to Follow-up Care Among Asian American Breast Cancer Survivors
Use of Pre-Operative Hypnosis to Reduce Post-Operative Pain and Anesthesia Related Side-Effects
Fontana : Research Site:
Fountain Valley : Research Site:
Fountain Valley : Pacific Coast Hematology/Oncology Medical Group, Inc.
Fresno : Research Site
Capecitabine (Xeloda) With Or Without GW572016 For Women With Refractory Advanced Or Metastatic Breast Cancer.
Fullerton : Research Site:
Fullerton : Research Site
Glendale : Glendale Memorial Hospital & Health Center, Hematology/Oncology Department
Glendora : Research Site:
Greenbrae : California Cancer Care
Greenbrae : California Cancer Care Inc
Hawthorne : Research Site:
Hayward : Research Site:
Huntington Beach : Research Site:
Irvine : Research Site:
La Jolla : Research Site:
La Mesa : Research Site:
La Verne : Wilshire Oncology Medical Group, Inc.
A trial of 2 Schedules of Ixabepilone plus Bevacizumab and Paclitaxel Plus Bevacizumab for Breast Cancer
Lancaster : Research Site:
Little Rock : California Oncology of the Central Valley
Long Beach : Research Site:
Long Beach : Breastlink Medical Group Inc
Los Alamitos : Research Site:
Los Angeles : UCLA
A Pivotal Study to Evaluate the Effectiveness and Safety of ExAblate Treatment (Magnetic Resonance-guided Focused Ultrasound) of Metastatic Bone Tumors or Multiple Myeloma for the Palliation of Pain in Patients Who are not Candidates for Radiation Therapy
A Study of Dasatinib (BMS-354825) in Patients With Advanced ‘Triple-Negative’ Breast Cancer
Los Angeles : Research Site:
A Study of Herceptin (Trastuzumab) in Combination Chemotherapy in Patients With Advanced Breast Cancer
Los Angeles : East Valley Hematology And Oncology Medical Group, Inc.
Los Angeles : Merck
XeNA study - A Study of Xeloda (Capecitabine) in Patients With Invasive Breast Cancer
Mission Hills : Research Site:
Modesto : Research Site:
Montebello : Research Site:
Monterey Park : Research Site
Northridge : Research Site:
Oakland : Research Site:
Oceanside : Research Site:
Oxnard : Research Site:
Oxnard : Research Site
Palm Springs : Comprehensive Cancer Center
A Neoadjuvant Study of AC Followed by Ixabepilone or Paclitaxel in Early Stage Breast Cancer That is HER-2 Negative and Estrogen Receptor Negative
Palm Springs : Palm Springs Desert Regional Medical Center - Comprehensive Cancer Center
Palm Springs : Research Site:
Panorama City : Research Site:
Pasadena : Research Site:
Pleasant Hill : Research Site:
Pomona : Research Site:
Pomona : Research Site
Rancho Cucamonga : Research Site:
Redondo Beach : Research Site:
Riverside : Research Site:
Riverside : ClinicAid Research Management/Compassionate Cancer Care Medical Group-Riverside
Roseville : Research Site:
Sacramento : Research Site:
Sacramento : Sutter Cancer Center
San Diego : University of California San Diego Medical Center
San Diego : Research Site:
San Francisco : Ucsf-Comprehensive Cancer Center
San Francisco : Research Site:
San Francisco : UCSF Comprhensive Cancer Center
San Francisco : California Pacific Medical Center
San Francisco : University of California San Francisco
Study of Dasatinib (BMS-354825) in Patients with Advanced Estrogen/Progesterone Receptor-Positive (ER+/PR+) or Her2/Neu-Positive (Her2/Neu+) Breast Cancer
San Jose : Research Site:
Santa Barbara : Research Site:
Santa Barbara : Research Site
Santa Clara : Research Site:
Santa Maria : Research Site:
Santa Monica : Research Site:
Solvang : Research Site:
South San Francisco : Research Site:
Stanford : Research Site:
Stanford : Stanford University School of Medicine
Stress and Breast Cancer Study
Study of self-conscious emotions in women living with breast cancer
Sylmar : Research Site:
Valencia : Research Site:
Vallejo : Research Site:
HER2-positive Metastatic Breast Cancer Study CLBH589C2204
Walnut Creek : Research Site:
West Covina : Research Site:
Whittier : Research Site:
Woodland Hills : Research Site:
Colorado
Aurora : Research Site:
Aurora : University of Colorado Hospital - Anschutz Cancer Pavilion
Aurora : University Of Colorado Cancer Center
Colorado Springs : Research Site:
Denver : Research Site:
Denver : Merck
Edwards : Research Site:
Fort Collins : Front Range Cancer Specialists
Ft Collins : Front Range Cancer Specialists
Grand Junction : Research Site:
Greeley : Research Site:
Lafayette : Research Site:
Longmont : Research Site:
Loveland : Research Site:
Thornton : Research Site:
Wheat Ridge : Research Site:
Connecticut
Bridgeport : Research Site:
Fairfield : Research Site:
Farmington : Research Site:
Hartford : Research Site:
Meriden : Research Site:
Middletown : Connecticut Oncology Group
New Haven : Research Site:
A Study of Epothilone D in Patients With Metastatic Breast Cancer
Norwich : Research Site:
Stamford : Research Site:
Stamford : Hematology Oncology PC-Bennett Cancer Center
Trumbull : Oncology Associates of Bridgeport, P.C.
Trumbull : Oncology Associates of Bridgeport
Waterbury : Research Site:
Delaware
Newark : Research Site:
Florida
Aventura : South Florida Medical Research
Phase II, Clinical Trial For Patients with Prostate Cancer or Breast Cancer with Metastatic Disease
Prostate Cancer/Breast Cancer study to evaluate the safety and effects on bone resorption of a study medication compared to another approved drug in patients with Metastatic Disease.
Boca Raton : Research Site:
Bonita Springs : Research Site:
Boynton Beach : Research Site:
Boynton Beach : Palm Beach Institute of Hematology and Oncology
Bradenton : Research Site:
Brooksville : Pasco Hernando Oncology Associates, Inc
Cape Coral : Research Site:
Coral Spring : Northwest Oncology & Hematology Associates
Coral Springs : Research Site:
Davie : Florida Cancer Research Institute
Davie : Research Site:
Daytona Beach : Halifax Medical Center
Englewood : Research Site:
Fort Lauderdale : Research Site:
Fort Lauderdale : Holy Cross Hospital, Michael & Dianne Bienes Cancer Center
Fort Myers : Research Site:
Gainesville : Gainesville Hematology Oncology Associates
A Phase II study of Abraxane and Nexavar in the First-line Treatment of Locally Advanced or Metastatic Breast Cancer
Gainesville : Research Site:
Hialeah : Merck
Hollywood : Research Site:
Hudson : Florida Cancer Institute
Jacksonville : Mayo Clinic Jacksonville
Jacksonville : Research Site:
Jacksonville Beach : Research Site:
Lake Worth : Hematology Oncology Associates
Lake Worth : Medical Specialists of the Palm Beaches, Inc.
Lake Worth : Research Site:
Lakeland : Research Site:
Melbourne : Research Site:
Miami : Research Site:
Miami : Research Site
Naples : Research Site:
New Port Richey : Pasco Hernando Oncology Associates PA
Orange Park : Research Site:
Orlando : Research Site:
Orlando : M.D. Anderson Cancer Center Orlando
Palatka : Research Site:
Palm Beach Gardens : Research Site:
Plantation : Research Site:
Plantation : Research Site
Port Charlotte : Research Site:
Port St Lucie : Research Site:
Port St. Lucie : Research Site
Sarasota : Research Site:
St. Augustine : Research Site:
St. Petersburg : Gulfcoast Oncology Associates
Tamarac : Research Site:
Tampa : Moffitt Cancer Center
Tampa : Research Site:
Venice : Research Site:
West Palm Beach : Research Site:
West Palm Beach : Palm Beach Cancer Institute
The purpose of this study is to determine whether RTA 744 is effective in the treatment of breast cancer that has metastasized to the brain.
Weston : Research Site:
Winter Park : Research Site:
Georgia
Savannah : Memorial Health University Medical Center
BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab NSABP B-44-I
First-Line Chemotherapy and Trastuzumab With or Without Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU ECOG E1105
Albany : Research Site:
Altanta : Peachtree Hematology & Oncology Associates
Athens : Research Site:
Atlanta : Research Site:
Atlanta : Emory University
Augusta : Research Site:
Augusta : Augusta Oncology Associates
Austell : Research Site:
Carrolton : Research Site:
Cartersville : Research Site:
Douglasville : Research Site:
Duluth : Research Site:
Lawrenceville : Research Site:
Macon : Research Site:
Macon : Central Georgia Cancer Care
Marietta : Research Site:
Marietta : Northwest Georgia Oncology Centers, PC
Marietta : Research Site
Marietta : NW Georgia Oncology Center
A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer
ACOSOG Z1031: A Randomized Phase III Trial Comparing 16 to 18 Weeks of Neoadjuvant Drugs in Postmenopausal Women with Clinical Stage II/III Breast Cancer
Savannah : Research Site:
Bevacizumab and Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone in Treating Patients With Locally Recurrent, Stage IIIB, or Stage IV Breast Cancer
Savannah : Memorial Health University Medical Center New!
Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery NSABP B-40
Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the Bone SWOG S0622
Granisetron, Dexamethasone, Prochlorperazine, Aprepitant, and Palonosetron in Preventing Nausea in Patients Undergoing Chemotherapy for Breast Cancer URCC U1105
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) ECOG PACCT-1
Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Suppression of Ovarian Function Plus Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer CTSU/IBCSG 24-02
Treatment With Pazopanib for Neoadjuvant Breast Cancer
Using the Conture® Multi-Lumen Balloon to Deliver Accelerated Partial Breast Brachytherapy
Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement
Snellville : Research Site:
Stockbridge : Center of Hope for Cancers and Blood Disorders
Tucker : Research Site:
Valdosta : Research Site:
Hawaii
Honolulu : Research Site:
Idaho
Boise : Research Site:
Coeur D'Alene : Research Site:
Fruitland : Research Site:
Meridian : Research Site:
Nampa : Research Site:
Twin Falls : Research Site:
Illinois
Arlington Heights : Research Site:
Centralia : Southern Illinois Hematology/Oncology
This is a Phase 2 study to evaluate the efficacy and safety of NKTR-102 (a pegylated Irinotecan) in patients with breast cancer.
Chicago : Research Site:
Chicago : Merck
Chicago : Robert H Lurie Comprehensive Cancer Center at Northwestern University
Chicago : Rush University Medical Center - Treatment Research Center
The Impact of Intestinal Bacteria on Breast Cancer
Decatur : Cancer Care Specialists of Central Illinois
Elgin : Research Site:
Elgin : Sherman Health Systems
E5103 “A Double-Blind Phase III Trial of Doxorubicin and Cyclophosphamide followed by Paclitaxel with Bevacizumab or Placebo in Patients with Lymph Node Positive and High Risk Lymph Node Negative Breast Cancer”
NSABP B-42: A Clinical Trial to Determine the Efficacy of Five Years of Letrozole Compared to Placebo in Patients Completing Five Years of Hormonal Therapy Consisting of an Aromatase Inhibitor (AI) or Tamoxifen Followed by an AI in Prolonging Disease-Free Survival in Postmenopausal Women with Hormone Receptor Positive Breast Cancer
Harvey : Ingalls Memorial Hospital (Monroe Medical)
Hines : Merck
Maywood : Loyola University Medical Center
Napersville : Research Site:
Naperville : Research Site:
Niles : Research Site:
Park Ridge : Research Site:
Peoria : Research Site
Quincy : Research Site:
Quincy : Quincy Medical Group
Winfield : Research Site:
Zion : Research Site:
Indiana
Bedford : Research Site:
Beech Grove : Research Site:
Bloomington : Research Site:
Indianapolis : Research Site:
Munster : Research Site:
New Albany : Research Site:
New Albany : Cancer Care Center
South Bend : Northern Indiana Cancer Research Consortium
Terre Haute : Research Site:
Vincennes : Research Site:
Iowa
Bettendorf : Research Site:
Davenport : Research Site:
Iowa City : Research Site:
Iowa City : University Of Iowa Hospitals And Clinics
Waterloo : Research Site:
Kansas
Kansas City : Research Site:
Overland Park : Research Site:
Westwood : Research Site:
Wichita : Research Site:
Kentucky
Hazard : Research Site:
Lexington : Research Site:
Lexington : University of Kentucky Chandler Medical Center
Cancer: Breast Cancer Research Study
Rehabilitation: Research Study on Arm Use in Women With and Without Breast Cancer
LOUISVILLE : UNIVERSITY MEDICAL CENTER, INC
Louisville : James Graham Brown Cancer Center
Louisville : Research Site:
Louisville : Norton Health Care
Louisiana
Baton Rouge : Research Site:
Baton Rouge : Mary Bird Perkins Cancer Center
Metairie : Research Site:
Shreveport : Research Site:
Maine
Bangor : Research Site:
Scarborough : Research Site:
Scarborough : Maine Center for Cancer Medicine & Blood Disorders
Scarbrough : Maine Center for Cancer Medicine
Maryland
Baltimore : Research Site:
Baltimore : Harbor View Cancer Center
Baltimore : Greater Baltimore Medical Center, Cancer Center
Baltimore : Cancer Center at Greater Baltimore Medical Center
Bethesda : Research Site:
Chevy Chase : Research Site:
Frederick : Research Site:
Rockville : Research Site:
Salisbury : Research Site:
Silver Spring : Research Site:
Massachusetts
Boston : Brigham and Women's Hospital
Boston : Dana-Farber Cancer Inst
Boston : Research Site:
Boston : Boston Medical Center
Burlington : Lahey Clinic
A Pivotal Study to Evaluate the Effectiveness and Safety of ExAblate Treatment of Metastatic Bone Tumors for the Palliation of Pain in Patients Who are not Candidates for Radiation Therapy
Peabody : North Shore Medical Center, Cancer Center
Pittsfield : Research Site:
Plymouth : Research Site:
Springfield : Baystate Medical Center
Michigan
Ann Arbor : Research Site:
Ann Arbor : University of Michigan Comprehensive Cancer Center
Detroit : Research Site:
East Lansing : Research Site:
Escanaba : Research Site:
Flint : Research Site:
Free Soil : Research Site:
Grand Rapids : Research Site:
Hancock : Research Site:
Iron Mountain : Research Site:
Ironwood : Research Site:
Jackson : Research Site:
Kalamazoo : Research Site:
Lansing : Research Site:
Laurium : Research Site:
Marquette : Research Site:
Royal Oaks : Research Site:
Saint Joseph : Research Site:
Sault St. Marie : Research Site:
Southfield : Research Site:
Traverse City : Research Site:
Woodhaven : Research Site:
Minnesota
Edina : Research Site:
Fridley : Research Site:
Maplewood : Research Site:
Minneapolis : Research Site:
Minneapolis : The University of Minnesota Cancer Center
Saint Louis Park : Research Site:
St Louis Park : Research Site:
Mississippi
South Haven : Research Site:
Missouri
Columbia : Ellis Fischel Cancer Center
Columbia : Research Site:
Jeferson City : Columbia Comprehensive Cancer Care Clinic & Research Institute
Jefferson City : Research Site:
Joplin : Research Site:
Kansas City : Kansas City Cancer Center
Saint Louis : Merck
Springfield : Research Site:
St Joseph : Research Site:
St Louis : Research Site:
St. Louis : Research Site:
St. Louis : St. John's Mercy Medical Center, David C. Pratt Cancer Center
Montana
Billings : Research Site:
Great Falls : Research Site:
Great Falls : Research Site
Nebraska
Lincoln : Research Site:
Omaha : Research Site:
Omaha : Nebraska Methodist Hospital
Nevada
Carson City : Research Site:
Henderson : Research Site:
Las Vegas : Research Site:
Las Vegas : Research Site
Reno : Research Site:
New Hampshire
Lebanon : Research Site:
New Jersey
Basking Ridge : Memorial Sloan-Kettering Cancer Center: Basking Ridge, NJ
Denville : Oncology & Hematology Specialists, PA
Englewood : Drs. Forte, Schleider, & Attas, P.A.
Hackensack : Research Site:
Hamilton : Research Site:
Livingston : Research Site:
Livingston : Saint Barnabas Medical Center Cancer Center
Livingston : St. Barnabas Medical Center
Long Branch : Monmouth Medical Center
Long Branch : Research Site:
Morristown : Atlantic Health System
A Study to Evaluate the Safety, Tolerability, and Activity of Lonafarnib and Docetaxel (Study P04467AM1)
Morristown : Research Site:
Mountain Lakes : Research Site:
Neptune : Research Site:
New Brunswick : Research Site:
Newark : Merck
Paramus : Research Site:
Paramus : The Valley Hospital/Valley Health System
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
Red Bank : Research Site:
Sparta : Research Site:
Summit : Research Site:
Voorhees : Research Site
Vorhees : Virtua Health
New Mexico
ALBUQUERQUE : UNIVERSITY OF NEW MEXICO CANCER CENTER
Albuquerque : Research Site:
Santa Fe : Research Site:
Santa Fe : Research Site
New York
Brockport : Research Site:
Bronx : Albert Einstein Cancer Center
Bronx : Montefiore Medical Center
Bronx : Research Site:
Bronx : Our Lady of Mercy Medical Center - Comprehensive Cancer Center
Buffalo : Roswell Park Cancer Institute
Canandaigua : Research Site:
Commack : Memorial Sloan-Kettering Cancer Center: Suffolk
East Syracuse : Research Site:
East Syracuse : Merck
East Syracuse : Hematology Oncology Associates of Central New York
Elmhurst : Research Site:
Elmhurst : Biomedical Research Alliance of New York
Observational Study of Treatment for Breast Cancer - Adults
Geneva : Research Site:
Glenn Falls : Research Site:
Jamaica : Biomedical Research Alliance of New York
Adults with Breast Cancer are asked to participate in a research study being conducted by Queens Hospital Center. This study is to compare an investigation product not approved by the FDA versus a commercially approved product by the FDA in adults with advance breast cancer.
HER2-positive Locally Recurrent or Metastatic Breast Cancer
Jamaica : Queens Cancer Center
Study of Tamoxifen and Raloxifene for the Prevention of Breast Cancer (STAR)
Johnson City : Broome Oncology, LLC
Lake Success : Research Site:
Lake Success : Biomedical Research Alliance of New York
Breast Cancer - Adults
HER2-Positive Locally Advanced or Metastatic Breast Cancer - Adults
New Hyde Park : Research Site:
New York : Memorial Sloan Kettering Cancer Center
New York : Cornell University
New York : Research Site:
New York : Weill Cornell Breast Center
New York : Memorial Sloan-Kettering Cancer Center
New York : Mount Sinai Medical Center
Immunomodulatory Gene Therapy in Patients with Metastatic Breast Cancer: Phase 1 Trial of Adenoviral Vector Delivery of the Human Interleukin-12 cDNA by Intraturmoral Injection in Patients with Metastatic Breast Cancer
New York : Weill Cornell Breast Cancer
New York : Weill Medical College Of Cornell University
Poughkeepsie : Vassar Brothers Medical Center
A Clinical Trial to Determine the Efficacy of Five Years of Letrozole Compared to Placebo in Patients Completing Five Years of Hormonal Therapy Consisting of an Aromatase Inhibitor (AI) or Tamoxifen Followed by an AI in Prolonging Disease-Free Survival in Postmenopausal Women with Hormone Receptor Positive Breast Cancer.
A Randomized Phase III Study of Conventional Whole Breast Irradiation (WBI) vs. Partial Breast Irradiation (PBI) for Women with Stage 0, I, or II Breast Cancer
ECOG 5103 - "A Double-Blind Phase III Trial of Doxorubicin and Cyclophosphamide followed by Paclitaxel with Bevacizumab or Placebo in Patients with Lymph Node Positive and High Risk Lymph Node Negative Breast Cancer
Study comparing Anastrozole vs. anastrozole and fulvestrant for post-menopausal women with metastic breast cancer.
Rochester : Research Site:
Rochester : Merck
Rockville Centre : Memorial Sloan-Kettering Cancer Center: Rockville Center
Sleepy Hollow : Memorial Sloan-Kettering Cancer Center: Phelps
Stony Brook : Research Site:
The ?Bolero-3? HER2 Advanced or Metastatic Breast Cancer Trial
Williamsville : Research Site:
North Carolina
Asheville : Research Site:
Burlington : Research Site:
Cary : Research Site:
Chapel Hill : Research Site:
Chapel Hill : University Of North Carolina At Chapel Hill
Charlotte : Research Site:
Charlotte : Presbyterian Hospital
Durham : Research Site:
Durham : Duke University
Goldsboro : Research Site:
Greensboro : Research Site:
Hickory : Research Site:
Huntersville : Research Site:
Matthews : Research Site:
Wilson : Research Site:
Winston-Salem : Research Site:
Winston-Salem : Forsyth Regional Cancer Center
North Dakota
Bismarck : St. Alexius Medical Center
An oncology study for women with previously diagnosed breast cancer
Ohio
Akron : Research Site:
Canton : Research Site:
Canton : Aultman Hospital, Medical Oncology Department
Cincinnati : Research Site:
Cleveland : Research Site:
Columbus : Research Site:
Columbus : The Mark H. Zangmeister Center(formerly Mid Ohio Oncology/Hematology Inc)
Dayton : Research Site:
Greenville : Research Site:
Kettering : Research Site:
Middletown : Research Site:
Sandusky : North Coast Cancer Care
Toledo : Research Site:
Troy : Research Site:
Wilmington : Research Site:
Xenia : Research Site:
Oklahoma
Lawton : Cleo Craig Memorial Cancer Research
Norman : Research Site:
Oklahoma City : Research Site:
Tulsa : Research Site:
Oregon
Beaverton : Research Site:
Portland : Research Site:
Portland : Oregon Health and Science University Hematology/Oncology
Pennsylvania
Allentown : Research Site:
Bryn Mawr : Research Site:
Danville : Research Site:
Dunmore : Hematology & Oncology Associates of Northeastern PA
Dunore : Research Site:
Ephrata : Research Site:
Hershey : Research Site:
Kittanning : Research Site:
Media : Research Site:
Paoli : Research Site:
Philadelphia : Fox Chase Cancer Center
Philadelphia : Research Site:
Philadelphia : Pennsylvania Hematology Oncology Associates
Pittsburgh : Research Site:
Pittsburgh : Magee Womens Hospital
Pittsburgh : Magee-Womens Hospital
Scranton : Research Site:
State College : Research Site:
Willow Grove : Abington Hematology Oncology
Wynnewood : Research Site:
York : York Cancer Center
York : Research Site:
Rhode Island
Providence : Research Site:
Providence : Merck
South Carolina
Beaufort : Research Site:
Charleston : Research Site:
Charleston : Charleston Hematology Oncology Associates, PA
Florence : Research Site:
Georgetown : Research Site:
Sumter : Research Site:
Tennessee
Bristol : Research Site:
Chattanooga : Research Site:
Collierville : Family Cancer Center
Germantown : Research Site:
Johnson City : Research Site:
Kingsport : Research Site:
Knoxville : Research Site:
Knoxville : Tennessee Cancer Specialists
Maryville : Research Site:
Memphis : Research Site:
Memphis : Research Site
Memphis : The West Clinic
Nashville : Research Site:
Texas
Austin : Southwest Regional Cancer Center
Austin : Research Site:
Corpus Christi : Research Site:
Dallas : Research Site:
Dallas : Research Site
Dallas : Texas Oncology, PA
El Paso : Research Site:
Fort Worth : Research Site:
Fredericksburg : Research Site:
Houston : The Methodist Hospital Research Institute
Houston : University Of Texas Md Anderson Cancer Ctr
Houston : Research Site:
A Study of Xeloda (Capecitabine) in Women With High-Risk Breast Cancer
Houston : Merck
Houston : The University of Texas - M.D. Anderson Cancer Center
Houston : S. R. Burzynski Clinic
Phase II Study Of Antineoplastons A10 And AS2-1 In Patients With Carcinoma Of The Breast
Phase II Study Of Private Antineoplaston A10 And AS2-1 Capsules In Patients With Advanced Breast Cancer
Phase II Study Of Private Antineoplaston A10 In Combination With Low Dose Methotrexate In Patients With Advanced Breast Cancer
Irving : Research Site
Kerrville : Research Site:
Lubbock : Research Site:
Plano : Research Site:
San Antonio : Research Site:
San Antonio : South Texas Oncology & Hematology
San Antonio : South Texas Oncology and Hematology
Utah
Murray : Research Site:
Ogden : Research Site:
Provo : Research Site:
Salt Lake City : Research Site:
St. George : Research Site:
Breast Cancer Study CZOL446E2105
Vermont
Rutland : Research Site:
Virginia
Abingdon : Research Site:
Charlottesville : University of Virginia New!
Are you having Breast Cancer Surgery?
Cancer Center seeks women ages 21 to 64 who have a new primary diagnosis of Breast Cancer for a research study
Patients with breast cancer sought for research study.
Seeking female volunteers ages 18-80 for whom a breast biopsy has been recommended for 3D imaging
Women age 18 and older needed to participate in a research study.
Chesapeake : Research Site:
Fairfax : Research Site:
Newport News : Research Site:
Norfolk : Research Site:
Richmond : Virginia Commonwealth University, Medical Oncology Department
Richmond : Research Site:
Virginia Beach : Research Site:
Washington
Bellevue : Research Site:
Kirkland : Cascade Cancer Center
Olympia : Research Site:
SEATTLE : VIRGINIA MASON MEDICAL CENTER
Seattle : Research Site:
Seattle : Swedish Cancer Institute
Seattle : Merck
Spokane : Providence Cancer Center
Spokane : Research Site:
Tacoma : Research Site:
Tacoma : Multicare Health System
Vancouver : Research Site:
Walla Walla : Research Site:
Washington, DC
Washington : Research Site:
Washington : Georgetown University Medical Center
Washington : Washington Cancer Institute
Washington : Georgetown University Medical Center - Lombardi Cancer Center
West Virginia
Morgantown : West Virginia University - Clinical Trials Research Unit
A Phase III Study of SU011248 in Combination with Paclitaxel versus Bevacizumab with Paclitaxel in the First-Line Advanced Disease Setting in Patients Having Breast Cancer (A6181094)
Morgantown : Research Site:
Wisconsin
Glendale : Oncology Alliance
Green Bay : Research Site:
Marshfield : Research Site:
Milwaukee : Research Site:
Minocqua : Research Site:
Wauwatosa : Research Site:
Argentina
Buenos Aires : Corporacion Medica De General San Martin
Buenos Aires : Hospital Britanico De Buenos Aires
Buenos Aires : Research Site:
A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab)/Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.
A Study of Avastin (Bevacizumab) plus Taxane-Based Therapy in Patients With Locally Recurrent or Metastatic Breast Cancer.
A Study to Compare Subcutaneous Versus Intravenous Administration of Herceptin (Trastuzumab) in Women With HER2Positive Early Breast Cancer
HERA study - A Study of Intravenous Herceptin (Trastuzumab) in Women With HER2-Positive Primary Breast Cancer
Caba : Research Site:
Capital Federal : Hospital Italiano De Buenos Aires
Chaco-Resistencia : Research Site:
Cordoba : Research Site:
Córdoba : Research Site:
La Pampa : Research Site:
La Plata : Research Site:
Mar Del Plata : Research Site:
Mendoza : Research Site:
Neuquén : Research Site:
Pilar : Research Site:
Rosario : Research Site:
Salta : Research Site:
San Martin : Research Site:
Tucuman : Research Site:
Australia
Adelaide : Research Site:
A Study of Herceptin (Trastuzumab) in Women With HER2-Positive Advanced and/or Metastatic Breast Cancer
Brisbane : Research Site:
A Continuation Study of Herceptin (Trastuzumab) in Patients With Metastatic Breast Cancer
A Study of Avastin (Bevacizumab) in Women With HER2 Negative Metastatic Breast Cancer
A Study of Herceptin (Trastuzumab) Monotherapy in Women With Metastatic Breast Cancer
Campbelltown : Research Site:
Darlinghurst : Research Site:
East Bentleigh : Research Site:
A Dose Finding Study of Subcutaneous Herceptin (Trastuzumab) in Healthy Male Volunteers and HER2 Positive Female Patients
East Melbourne : Research Site:
East Ringwood : Research Site:
A Study of Herceptin (Trastuzumab)and Biomarkers in Patients With HER2-Positive Metastatic Breast Cancer
Fitzroy : Research Site:
A Study of Pertuzumab in Patients With Metastatic Breast Cancer
Frankston : Research Site:
Geelong : Research Site:
A Study of Herceptin (Trastuzumab) in Women With Metastatic Breast Cancer
Heidelberg : Research Site:
Hobart : Research Site:
Lismore : Research Site:
Liverpool : Research Site:
Malvern : Research Site:
Maroochydore : Research Site:
Milton : Research Site:
Nambour : Research Site:
Parkville : Research Site:
Perth : Research Site:
Port Macquarie : Research Site:
South Granville : Merck Sharp & Dohme (Australia) Pty Ltd.
Southport : Research Site:
St. Leonards : Research Site:
Sydney : Research Site:
Toowoomba : Research Site:
Waratah : Research Site:
Wodonga : Research Site:
Wollongong : Research Site:
Austria
Bludesch : Research Site:
Bregenz : Research Site:
Dornbirn : Research Site:
Graz : Research Site:
Innsbruck : Research Site:
A Study of Herceptin (Trastuzumab) in Combination With Avastin (Bevacizumab) and Sequential Xeloda (Capecitabine) or Docetaxel in Patients With HER2-Positive Locally Recurrent or Metastatic Breast Cancer
Klagenfurt : Research Site:
Krems : Research Site:
Kufstein : Research Site:
Leoben : Research Site:
Linz : Research Site:
Oberwart : Research Site:
Rankweil : Research Site:
Salzburg : Research Site:
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Primary Breast Cancer
St Pölten : Research Site:
St Veit an der Glan : Research Site:
Steyr : Research Site:
Villach : Research Site:
Vöcklabruck : Research Site:
Wels : Research Site:
Wien : Research Site:
A Study of Herceptin (Trastuzumab) in Combination Chemotherapy in Women With Locally Advanced Breast Cancer
Wie
